Loading...
Kintara Therapeutics, Inc.
KTRA•NASDAQ
HealthcareBiotechnology
$0.22
$-0.01(-6.31%)
Kintara Therapeutics, Inc. (KTRA) Financial Performance & Statements
Review Kintara Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
42.58%
↑ 42.58%
Net Income Growth
41.97%
↑ 41.97%
Operating Cash Flow Growth
39.52%
↑ 39.52%
Operating Margin
5468.42%
↑ 5468.42%
Gross Margin
39.47%
↑ 39.47%
Net Profit Margin
-17576.92%
↓ 17576.92%
ROE
-251.68%
↓ 251.68%
ROIC
42.17%
↑ 42.17%
Kintara Therapeutics, Inc. (KTRA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Kintara Therapeutics, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $76000.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $38000.00 | $8000.00 | $15000.00 | $15000.00 |
| Gross Profit | $38000.00 | -$8000.00 | -$15000.00 | -$15000.00 |
| Gross Profit Ratio | $0.50 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $101000.00 | $592000.00 | $111000.00 | $1.86M |
| SG&A Expenses | $2.31M | $1.49M | $893000.00 | $1.10M |
| Operating Expenses | $2.41M | $2.08M | $1.004M | $2.96M |
| Total Costs & Expenses | $2.45M | $2.08M | $1.02M | $2.96M |
| Interest Income | $61000.00 | $0.00 | $2000.00 | $2000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | -$38000.00 | $8000.00 | $15000.00 | $15000.00 |
| EBITDA | -$2.37M | -$2.08M | -$1.004M | -$2.95M |
| EBITDA Ratio | -$33.09 | $0.00 | $0.00 | $0.00 |
| Operating Income | $6.24M | -$2.08M | -$1.02M | -$3.14M |
| Operating Income Ratio | $82.12 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $61000.00 | $74000.00 | -$3999.00 | $0.00 |
| Income Before Tax | -$2.51M | -$2.01M | -$1.02M | -$2.96M |
| Income Before Tax Ratio | -$32.96 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $28278.00 | -$1.00 | -$1.00 | -$28276.00 |
| Net Income | -$2.51M | -$2.01M | -$1.02M | -$2.96M |
| Net Income Ratio | -$32.96 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.95 | -$0.92 | -$0.47 | -$1.72 |
| Diluted EPS | -$0.95 | -$0.45 | -$0.24 | -$1.72 |
| Weighted Avg Shares Outstanding | $2.64M | $4.46M | $4.34M | $1.72M |
| Weighted Avg Shares Outstanding (Diluted) | $2.64M | $4.46M | $4.34M | $1.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan